Physician profile
Ron Landmann
NPI 1407013592
$224,300.71
in general payments reported to CMS, 2019-2025
13 companies · $6,586 in 2025
The $6,586 reported for 2025 was more than what 91% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $42K · 2021: $62K · 2022: $72K · 2023: $12K · 2024: $9,767 · 2025: $6,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $3,309 · Travel and Lodging: $2,926 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,605.56 |
| Food and Beverage | $3,308.65 |
| Travel and Lodging | $2,926.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $169,829.28 | 2019-2025 | Echelon; Endopath, Harmonic, Echelon Flex |
| Medical Device Business Services, INC. | $32,870.13 | 2019-2025 | Echelon Flex, Enseal |
| Ethicon US, LLC | $12,418.89 | 2019-2025 | Echelon Flex, Echelon; Endopath, Enseal |
| Davol INC. | $3,757.78 | 2022-2023 | |
| Intuitive Surgical, INC. | $2,631.07 | 2019-2025 | Da Vinci Surgical System |
| Ethicon Endo-Surgery INC. | $1,151.82 | 2019 | |
| Ambu INC. | $1,105.30 | 2021-2023 | |
| Medtronic, INC. | $170.44 | 2021-2023 | |
| On Target Laboratories, INC | $149.98 | 2024 | Cytalux |
| Boston Scientific Corporation | $143.34 | 2024 | |
| Reddress USA, INC. | $45.44 | 2024 | |
| Tela Bio, INC. | $27.24 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Landmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.